Research Directory

Approvals of cancer drugs set record in 2012

Read more

Do oncolytic viruses have a future as combination therapies?

Read more

Diabetes reimbursement at risk in Germany

Read more

Unitary patent - for better or for worse?

Read more

2012 was the year of the antibody developer

Read more

Sofinnova's Investment Strategy: Putting the entrepreneur first

Read more

Are botanical drugs a new model for pharma?

Read more

Managers ignore pharmacovigilance at their peril

Read more

Adaptive licensing: A new approach for drug approvals

Read more

IMI: As Big Pharma pulls back, IMI steps in

Read more